Abstract

Mesoporous silicon has become a material of high interest for drug delivery due to its outstanding internal surface area and inherent biodegradability. We have previously reported the preparation of mesoporous silicon microparticles (MS-MPs) synthesized by an advantageous electrochemical method, and showed that due to their inner structure they can adsorb proteins in amounts exceeding the mass of the carrier itself. Protein release from these MS-MPs showed low burst effect and fast delivery kinetics with complete release in a few hours. In this work, we explored if tailoring the size of the inner pores of the particles would retard the protein release process. To address this hypothesis, three new MS-MPs prototypes were prepared by electrochemical synthesis, and the resulting carriers were characterized for morphology, particle size, and pore structure. All MS-MP prototypes had 90 µm mean particle size, but depending on the current density applied for synthesis, pore size changed between 5 and 13 nm. The model protein α-chymotrypsinogen was loaded into MS-MPs by adsorption and solvent evaporation. In the subsequent release experiments, no burst release of the protein was detected for any prototype. However, prototypes with larger pores (>10 nm) reached 100% release in 24–48 h, whereas prototypes with small mesopores (<6 nm) still retained most of their cargo after 96 h. MS-MPs with ∼6 nm pores were loaded with the osteogenic factor BMP7, and sustained release of this protein for up to two weeks was achieved. In conclusion, our results confirm that tailoring pore size can modify protein release from MS-MPs, and that prototypes with potential therapeutic utility for regional delivery of osteogenic factors can be prepared by convenient techniques.

Highlights

  • Mesoporous silicon (MS)-based materials are currently investigated in a variety of systems for drug delivery and tissue engineering applications (Anglin et al, 2008; Santos, 2014)

  • How to cite this article Pastor et al (2015), Pore size is a critical parameter for obtaining sustained protein release from electrochemically synthesized mesoporous silicon microparticles

  • The mesoporous structure of mesoporous silicon microparticles (MS-MPs) observed by high resolution Scanning Electron Microscopy (SEM) (Fig. 1C) revealed the regular and homogeneous pores propagated along a single direction, as it is common for electrochemically prepared MS

Read more

Summary

Introduction

Mesoporous silicon (MS)-based materials are currently investigated in a variety of systems for drug delivery and tissue engineering applications (Anglin et al, 2008; Santos, 2014). Silicates have FDA GRAS status, and even safety margins for silica nanoparticles administered intravenously start to be established (Yu et al, 2013). Inspired by these properties, researchers have investigated silicon-based carriers in a variety of formats (i.e., scaffolds, microparticles, nanoparticles, etc.) for delivering hydrophobic and hydrophilic drugs (Anglin et al, 2008; Prestidge et al, 2008; Salonen et al, 2008). MS-based materials have been proposed for delivering drug-loaded nanoparticles within the concept of multistage delivery vehicles (Tasciotti et al, 2008)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.